Skip to content Skip to navigation

Inflammation, Major Histocompatibility Class I and human brain development

Neurons in human cortical organoids express Major Histocompatibility Class I proteins (green)

Neurons in 200 day old human cortical organoids express Major Histocompatibility Class I proteins (MHCI), depicted in green.  MHCI negative astrocytes and neuronal progenitor cells are marked in red by glial fibrillary acidic protein (GFAP), while cell nuclei are shown in blue (DAPI). Image Credit: Michelle Drews

Maternal infection is linked to increased risk of neurodevelopmental disorders such as autism and schizophrenia. This proposal examines how virus-associated cytokines, specifically interferons, affect human neurons modeled in brain organoids or studied directly in fetal brain samples. In the immune system, interferons regulate expression of Major Histocompatibility Class I (MHCI) molecules, which perform antigen presentation for adaptive immunity. In contrast, in the nervous system, MHCIs expressed in neurons at synapses play unexpected and key roles in synaptic pruning and plasticity during development. These two separate roles for the same molecules raise the question of what happens when brain and immune systems collide as the developing brain experiences a viral infection. Our preliminary experiments suggest that human neurons express MHCI proteins. Moreover, interferon exposure significantly upregulates MHCI mRNA and protein, suggesting that perturbations in MHCI expression could contribute to the risk of CNS disorders associated with inflammation and viral infection during brain development.

About Wu Tsai Neuro Seed Grants

Participants

Lead Researcher(s): 

Additional Researcher

Michelle Drews

Funding Type: 
Seed Grant
Round: 
4
Award Year: 
2021